Since PCA3 is an emerging biomarker for prostate cancer, and that the expression of the TG STR in PCA3 gene is regulated by anti-androgen therapy in this study, we selected the TG-PCA3 STR for a genetic association analysis in a large cohort of prostate cancer patients and controls. This evidence concerns the gene PCA3 and prostate carcinoma.